Observational study of patients with non-small cell lung cancer (NSCLC) treated by erlotinib: Clinical practices and main outcomes in France (OBSTAR). Background: Tissue samples from tumors diagnosed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results